
    
      A structured standard questionnaire will be used to systematically collect essential data
      including demography, treatment history and concomitant infections and treatment.

      General and oral examination, collection of oral isolates, mycological, hematological and
      biochemical investigations will be done at baseline and at end of treatment day 13-14.

      All Patients will be followed up to 30 days after end of treatment for relapse
    
  